Dare Bioscience, Inc. — Director's Dealing 2024

Mar 14, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2024-03-12

Reporting Person: Haring-Layton MarDee (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-12	Employee Stock Option (right to buy)	$0.46	A	290000	Acquired	2034-03-12	Common stock (290000)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.